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Two main types of thyroid carcinomas may arise from the cells of follicular epithelium: 
papillary and follicular. These two types differ by their structure (though follicles are often 
present in papillary carcinomas), molecular-biological characteristics, and clinical behaviour. 
Besides, medullary thyroid carcinomas (derived from parafollicular neuroendocrine 
С-cells), as well as poorly differentiated and anaplastic carcinomas may occur in the 
gland. The two latter types of tumors may develop from preexisting well-differentiated 
tumors. Nonepithelial tumors developing from lymphoid cells (thyroid lymphoma) or from 
mesenchymal tissue components (thyroid sarcomas) are also known [1-4]. 
The following are definitions of the main types of thyroid carcinomas based on the WHO 
Histological classification [5]:
 • papillary thyroid carcinoma (PTC) is a malignant epitheliаl tumor derived from follicular 
cells, with characteristic changes in the nuclei (increased size, “ground glass” clearing, 
pseudo-intranuclear inclusions and grooves);
 • follicular thyroid carcinoma (FTC) is an encapsulated or partly encapsulated malignant 
epitheliаl tumor, derived from follicular cells, with signs of marked invasion into tumor 
capsule and/or tumor capsule vessels, without changes in tumor cell nuclei characteristic 
for PTC; 
 • medullary thyroid carcinoma (MTC) is a malignant tumor derived from С-cells; 
 • poorly differentiated thyroid carcinoma (PDTC) is a malignant tumor derived from 
follicular cells, with signs of decreased differentiation and being an intermediary 
between well-differentiated (PTC and FTC) and undifferentiated (anaplastic) thyroid 
carcinoma, both by histological structure, aggressiveness and clinical behaviour; 
 • anaplastic (undifferentiated) thyroid carcinoma (ATC) is the most malignant epitheliаl 
thyroid tumor derived from follicular cells, partly or completely consisting of 
undifferentiated cells. 
According to the above-mentioned classification, the present chapter describes 
and analyses the main types of thyroid carcinomas which were detected in the group 
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at increased risk for development of radiation-induced thyroid cancer in the period of a 
significant rise in its incidence after Chernobyl: 1990-2010 (see Chapter 3). A total of 2,960 
cases diagnosed in children and adolescents of Ukraine (aged 0 to 18 years at the time of 
the Chernobyl accident) as well as in those who were born after the accident are reviewed 
(Table 4.1).
Morphological characteristics of 2,658 thyroid carcinomas in individuals born before 
Chernobyl are considered for three age groups: children operated on at the age from 4 
to 14 years old, adolescents operated on at the age from 15 to 18 years old, and adults 
operated on at the age from 19 to 42 years old. Also, a comparative analysis of morphological 
changes is carried out for four time periods: 1990-1994, 1995-1999, 2000-2004, and 2005-
2010 (Table 4.2). Overall, 287 thyroid cancers in children (out of 453 detected in Ukraine, 
63.4%), 244 carcinomas in adolescents (out of 527 detected in Ukraine, 46.3%), and 2,127 
carcinomas in adults (out of 5,706 detected in Ukraine, 37.3%) were studied for the period 
1990-2010. Practically all cancers in children and adolescents included in the analysis have 
been additionally verified by the international experts, Professors VA LiVolsi and ED Williams, 
in the framework of joint international projects. Furthermore, 1,512 thyroid carcinomas 
in children, adolescents and adults operated in 1998-2010 included in the international 
Chernobyl Tissue Bank have been additionally verified by a Panel of experts-pathologists 
of the Project (see Chapter 6). It should be noted that since 2001, children born before 
Chernobyl were no longer registered because they naturally moved over to the age group 
of “adolescents” who, in turn, moved to the group of “adults” beginning from 2005. 
Table 4.1 
Total number of thyroid cancer cases under study
Type
Born before Chernobyl Born after Chernobyl
number % number %
PTC 2478 93.2 264 87.4
FTC 137 5.1 32 10.6
MTC 39 1.5 6 2.0
PDTC 4 0.2 - -
Total 2658 100 302 100
2960
PTC – papillary thyroid carcinoma; FTC – follicular thyroid carcinoma; MTC – medullary thyroid carcinoma; 
PDTC – poorly differentiated thyroid carcinoma
As shown in Table 4.2, among all cancers, papillary thyroid carcinoma was most 
prevalent, and accounted for more than 90% of cases in all age groups and for all time 
periods. This fully corresponds to the previously obtained numerous data published by 
scientists from Ukraine, Belarus, and Russian Federation [6-15], and to the findings of joint 
scientific projects carried out in cooperation between the affected countries and leading 
research centres of the world [16-25]. 
It has been established that PTC was the most common malignant thyroid tumor not 
only after internal radiation exposure, but also after external exposure of head and neck 
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area, especially in childhood [1-4,26-30]. Thyroid cancers that had been detected after 
Hiroshima and Nagasaki A-bombings [31-35] or the hydrogen bomb test in the Marshall 
Islands were also mainly PTCs  [36]. 
Table 4.2
Number of thyroid cancer cases in patients born before Chernobyl
Children aged up to 14 years at surgery
  1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
Type number % number % number % number % number %
PTC 127 97.0 135 93.1 10 90.1 - - 272 94.8
FTC 2 1.5 6 4.1 - - - - 8 2.8
MTC 2 1.5 4 2.8 1 0.9 - - 7 2.4
PDTC - - - - - - - - -
Total 131 100 145 100 11 100 - - 287 100
Adolescents aged from 15 to 18 years at surgery
  1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
  number % number % number % number % number %
PTC 27 96.4 81 92.0 117 91.4 - - 225 92.2
FTC 1 3.6 7 8.0 10 7.8 - - 18 7.4
MTC - - - - 1 0.8 - - 1 0.4
PDTC - - - - - - - - - -
Total 28 100 88 100 128 100 - - 244 100
Adults aged from 19 to 42 years at surgery
  1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
  number % number % number % number % number %
PTC 13 92.9 149 96.8 605 91.5 1214 93.5 1981 93.1
FTC 1 7.1 4 2.6 45 6.8 61 4.7 111 5.2
MTC - - 1 0.6 10 1.5 20 1.6 31 1.5
PDTC - - - - 1 0.2 3 0.2 4 0.2
Total 14 100 154 100 661 100 1298 100 2127 100
All age groups
  1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
  number % number % number % number % number %
PTC 167 96.5 365 94.3 732 91.5 1214 93.5 2478 93.2
FTC 4 2.3 17 4.4 55 6.9 61 4.7 137 5.1
MTC 2 1.2 5 1.3 12 1.5 20 1.6 39 1.5
PDTC - - - - 1 0.1 3 0.2 4 0.2
Total 173 100 387 100 800 100 1298 100 2658 100
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PTCs in Ukrainian patients varied in size from 0.3 to 75 mm. The analysis shows that the 
prevalence of tumors sized up to 10 mm (Table 4.3) - when combining all time periods - 
was increasing significantly and succesively in the age series: children (10/272, 3.7%) – 
adolescents (27/225, 12.0%) – adults (458/1981, 24.2%), p=0.0001 (here and hereafter, the 
Chi-square test for trend or Fisher’s Exact text are used for comparison of subgroups).
A significant ascending linear trend (р=0.0001) in the frequency of “small” PTCs was also 
noted for the combined age groups in time elapsed after Chernobyl, i.e. by time periods: 
1990-1994 (5/167, 3.0%) – 1995-1999 – (21/365, 5.7%) – 2000-2004 (95/732, 13.0%) – 2005 
-2010 (374/1214, 30.8%).  An inverse linear relationship was observed in the analysis of the 
frequency of carcinomas sized more than 40 mm (Table 4.3). The frequency was decreasing 
gradually and significantly (р=0.0001) both in age series: children (57 out of 272 cases, 20.9%) – 
adolescents (23 out of 225 cases, 10.2%) – adults (181 out of 1981 cases, 9.1%), 
and by time periods: 1990-1994 (33/167, 19.8%) – 1995-1999 (60/365, 16.5%) – 
2000-2004 (70/732, 9.5%) – 2005-2010 (98/1214, 8.1%). 
Analysis of small encapsulated tumors versus non-encapsulated or partly encapsulated 
did not reveal significant differences in age or time series. By contrast, significant ascending 
linear age and time trends (р=0.0001) were found for fully encapsulated large tumors 
(sized more than 40 mm): children (3 out of 57 cases, 5.3%) – adolescents (5 out of 23 cases, 
21.7%) – adults (84 out of 181 cases, 46.4%); 1990-1994 (1/33, 3.0%) – 1995-1999 (8/60, 
13.3%) – 2000-2004 (26/70, 37.1%) – 2005-2010 (56/98, 57.1%). 
For the combined encapsulated tumors of any size, significant ascending linear trends 
were also noted (р=0.0001): children (21 out of 272 cases, 7.7%) – adolescents (35 out of 
225 cases, 15.6%) – adults (582 out of 1981 cases, 29.4%); 1990-1994 (9/149, 6.0%) – 1995-
1999 (91/365, 24.9%) – 2000-2004 (172/732, 23.5%) – 2005-2010 (363/1214, 29.9%). 
PTC is generally known to display varying histological structures and therefore it is further 
subdivided into subtypes or variants.  According to the WHO Histological classification, 
these variants include classic papillary, follicular, macrofollicular, solid, oxyphilic-cell, 
clear-cell, diffuse-sclerosing, tall-cell, columnar-cell, cribriform-morular, and Warthin-like 
variants. Papillary microcarcinoma is also considered to be a separate variant [5]. 
With regard to the classic papillary variant, at least 80% of tumors featured typical 
papillary formations with characteristic fibrovascular core and optically clear (“ground-
glass”) nuclei (Fig. 4.1 A) containing intranuclear grooves and pseudo-cytoplasmic 
inclusions. Most of the tumor cells showed positive immunohistochemical staining with 
antithyroglobulin antibodies (Fig. 4.1 B).
In the  follicular  variant  of  PTC, typical papillary structures are scarce or absent (Fig. 
4.2 A). Cleared nuclei with chromatin localized at the periphery is the main distinctive 
feature of this subtype. Positive immunohistochemical reaction with antithyroglobulin 
antibodies, similarly to the classic papillary variant, was observed in most tumor cells 
(Fig. 4.2 B).
In the solid variant of papillary thyroid carcinoma, tumors with alveolar-solid growth 
pattern were most prevalent (Fig. 4.3 A). Areas with solid-trabecular structures were 
occasionally observed (Fig. 4.3 B). Papillary structures were generally absent, but small 
follicular areas could occur. The fact that tumors of this subtype are PTCs is substantiated 
by the structure of tumor cell nuclei. Intranuclear grooves and nuclear pseudoinclusions 
were best seen on electron microscopy (Fig. 4.3 D, E). Thyroglobulin in tumor cells, unlike in 
the classic papillary and follicular variants, was detected only focally (Fig. 4.3 C). 
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Table 4.3
Size of papillary thyroid carcinomas in patients born before Chernobyl
Size, mm
Children aged up to 14 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
up to 5 1 0.8 - - - - - - 1 0.4
6-10 2 1.6 7 5.2 - - - - 9 3.3
11-20 41 32.3 71 52.6 3 30.0 - - 115 42.3
21-30 41 32.3 17 12.6 5 50.0 - - 63 23.2
31-40 15 11.8 10 7.4 2 20.0 - - 27 9.9
41-50 15 11.8 18 13.4 - - - - 33 12.1
51-60 9 7.0 6 4.4 - - - - 15 5.5
> 60 3 2.4 6 4.4 - - - - 9 3.3
Total 127 100 135 100 10 100 - - 272 100
Adolescents aged from 15 to 18 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
up to 5 - - - - 6 5.1 - - 6 2.7
6-10 1 3.7 7 8.6 13 11.1 - - 21 9.3
11-20 10 37.0 38 46.9 51 43.6 - - 99 44.0
21-30 7 25.9 19 23.5 28 23.9 - - 54 24.0
31-40 5 18.6 7 8.7 10 8.6 - - 22 9.8
41-50 1 3.7 6 7.4 8 6.8 - - 15 6.7
51-60 - - 3 3.7 - - - - 3 1.3
>60 3 11.1 1 1.2 1 0.9 - - 5 2.2
Total 27 100 81 100 117 100 - - 225 100
Adults aged from 19 to 42 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
up to 5 - - - - 20 3.3 98 8.1 118 6.0
6-10 1 7.7 7 4.7 56 9.3 276 22.7 340 17.2
11-20 3 23.0 67 43.0 289 47.8 439 36.2 798 40.3
21-30 5 38.5 45 30.2 130 21.5 215 17.7 395 19.9
31-40 2 15.4 10 6.7 49 8.1 88 7.2 149 7.5
41-50 1 7.7 12 8.0 33 5.4 53 4.4 99 5.0
51-60 1 7.7 3 2.0 20 3.3 28 2.3 52 2.6
>60 - - 5 3.4 8 1.3 17 1.4 30 1.5
Total 13 100 149 100 605 100 1214 100 1981 100
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Continuation of Table 4.3
All age groups
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
up to 5 1 0.6 - - 26 3.6 98 8.1 125 5.0
6-10 4 2.4 21 5.7 69 9.4 276 22.7 370 14.9
11-20 54 32.3 176 48.2 343 46.9 439 36.2 1012 40.8
21-30 53 31.7 81 22.2 163 22.3 215 17.7 512 20.6
31-40 22 13.2 27 7.4 61 8.3 88 7.2 198 8.0
41-50 17 10.2 36 9.9 41 5.6 53 4.4 147 5.9
51-60 10 6.0 12 3.3 20 2.7 28 2.3 70 2.8
>60 6 3.6 12 3.3 9 1.2 17 1.4 44 1.8
Total 167 100 365 100 732 100 1214 100 2478 100
Figure 4.1. Classic papillary carcinoma. (A) Typical papillary structures with well-developed 
fibrovascular core and cleared tumor cell nuclei. Haematoxylin and eosin, original magnification 
x100. (B) Strong diffuse cytoplasmic immunostaining for thyroglobulin, original magnification x200. 
These three subtypes accounted for more than 50% of all PTCs under study for all age 
groups and all periods of time (Table 4.4).
Of note, PTCs were not always monomorphic histologically which is a difficulty when 
ascribing tumors to one of the three main variants.  In many cases tumors had a mixed 
growth pattern (herein referred to as “mixed variant”) (Fig. 4.4), comprising a combination 
of papillary, follicular or solid components (Table 4.5). 
Diffuse sclerosing variant was rather rare, 8.7% cases in children in the first period of time 
(Table 4.4). The frequency of this variant was significantly decreasing (р=0.0001) both in 
age and time series (Table. 4.4). Tumors with this structure were characterized by: 
 • diffuse extension of tumoral foci throughout the thyroid
 • fibrous-sclerotic changes
 • marked thyroiditis
 • abundance of psammoma bodies
 • foci of squamous-cell metaplasia.
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Figure 4.2. Follicular variant of papillary thyroid carcinoma. (A) Diffuse nuclear features of 
papillary carcinoma. Haematoxylin and eosin, original magnification x100. (B) Strong diffuse 
cytoplasmic immunostaining for thyroglobulin, original magnification x100. 
Figure 4.3. Solid variant of papillary thyroid carcinoma. (A) Alveolar-solid growth pattern. 
Haematoxylin and eosin, original magnification x100. (B) Trabecular growth pattern. Haematoxylin 
and eosin, original magnification x100. (C) Focal immunostaining for thyroglobulin, original 
magnification x50. (D) Intranuclear inclusions on electron microscopy, original magnification x5,000. 
(E) Nuclear grooves on electron microscopy, original magnification x7,000.
72
Chapter 4 
Tumoral foci had generally solid or papillary-solid structure. A marked invasion of tumor 
tissue and psammoma bodies to lymphatic vessels was characteristic (Fig. 4.5).
Figure 4.4. Mixed variant of papillary thyroid carcinoma. (A) Papillary-follicular growth pattern. 
Haematoxylin and eosin, original magnification x100. (B) Papillary-solid growth pattern. Haematoxylin 
and eosin, original magnification x50. (C) Solid-follicular growth pattern. Haematoxylin and eosin, 
original magnification x100.
Figure 4.5. Diffuse sclerosing variant of papillary thyroid carcinoma. (A) Diffuse tumor growth, 
numerous psammoma bodies, marked fibrosis, lymphocytic infiltration. Haematoxylin and eosin, 
original magnification x20. (B) Tumor aggregates inside lymphatic vessels. Haematoxylin and 
eosin, original magnification x100. (C) Squamous-cell metaplasia. Haematoxylin and eosin, original 
magnification x200.
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Table 4.4 
Subtypes of papillary thyroid carcinomas in patients born before Chernobyl
Subtype
Children aged up to 14 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
Number % number % number % number % number %
PV 9 7.1 19 14.1 2 20.0 - - 30 11.0
FV 46 36.2 17 12.6 2 20.0 - - 65 23.9
SV 38 29.9 17 12.6 2 20.0 - - 57 21.0
Mixed V 23 18.1 76 56.3 4 40.0 - - 103 37.9
DSV 11 8.7 6 4.4 - - - - 17 6.2
Warthin - - - - - - - - - -
Cribriform - - - - - - - - - -
Total 127 100 135 100 10 100 - - 272  
Adolescents aged from 15 to 18 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
PV 4 14.8 21 25.9 23 19.6 - - 48 21.3
FV 10 37.0 13 16.0 24 20.5 - - 47 20.9
SV 5 18.5 8 10.0 11 9.4 - - 24 10.7
Mixed V 8 29.7 35 43.2 58 49.6 - - 101 44.9
DSV - - 4 4.9 - - - - 4 1.8
Warthin - - - - 1 0.9 - - 1 0.4
Cribriform - - - - - - - - - -
Total 27 100 81 100 117 100 - - 225  
Adults aged from 19 to 42 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
PV 2 15.4 54 36.2 223 36.9 388 32.0 667 33.7
FV 6 46.1 30 20.1 102 16.9 194 16.0 332 16.8
SV 2 15.4 12 8.1 25 4.1 79 6.5 118 5.9
Mixed V 3 23.1 51 34.3 242 40.0 541 44.6 837 42.3
DSV - - 2 1.3 2 0.3 2 0.1 6 0.3
Warthin - - - - 11 1.8 8 0.7 19 0.9
Cribriform - - - - - - 2 0.1 2 0.1
Total 13 100 149 100 605 100 1214 100 1981 100
All age groups
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
PV 15 9.0 94 25.8 248 33.9 388 32.0 745 30.0
FV 62 37.1 60 16.4 128 17.5 194 16.0 444 17.9
SV 45 26.9 37 10.1 38 5.2 79 6.5 199 8.1
Mixed V 34 20.4 162 44.4 304 41.5 541 44.6 1041 42.0
DSV 11 6.6 12 3.3 2 0.3 2 0.1 27 1.1
Warthin - - - - 12 1.6 8 0.7 20 0.8
Cribriform - - - - - - 2 0.1 2 0.1
Total 167 100 365 100 732 100 1214 100 2478 100
PV – classic papillary variant; FV – follicular variant; SV – solid variant; Mixed V – mixed variant;




Structural components of mixed variant of papillary thyroid carcinoma in patients 
born before Chernobyl
Structure
Children aged up to 14 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
Number % number % number % number % number %
PF 3 13.0 12 15.8 1 25.0 - - 16 15.5
PS 4 17.4 7 9.2 - - - - 11 10.7
PFS 2 8.7 1 1.3 - - - - 3 2.9
SF 14 60.9 56 73.7 3 75.0 - - 73 70.9
Total 23   76   4 100 - - 103 100
 
Adolescents aged from 15 to 18 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
Number % number % number % number % number %
PF 1 12.5 12 34.9 25 43.1 - - 38 37.6
PS - - 7 20.0 11 19.0 - - 18 17.8
PFS - - - - 5 8.6 - - 5 5.0
SF 7 87.5 16 45.7 17 29.3 - - 40 39.6
Total 8   35 100 58 100 - - 101 100
 
Adults aged from 19 to 42 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
Number % number % number % number % number %
PF 2 75.0 20 39.2 148 61.2 252 46.6 422 50.4
PS - - 11 21.6 32 13.2 100 18.5 143 17.1
PFS - - 5 9.8 10 4.1 34 6.2 49 5.9
SF 1 25.0 15 24.4 52 21.5 155 28.7 223 26.6
Total 3 100 51 100 242 100 541 100 837 100
 
All age groups
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
Number % number % number % number % number %
PF 6 17.6 44 27.2 174 57.2 252 46.6 476 45.7
PS 4 11.8 25 15.4 43 14.1 100 18.5 172 16.5
PFS 2 5.9 6 3.7 15 5.0 34 6.2 57 5.5
SF 22 64.7 87 53.7 72 23.7 155 28.7 336 32.3
Total 34 100 162 100 304 100 541 100 1041  
PF – papillary-follicular variant; PS – papillary-solid variant; PFS – papillary-follicular-solid variant; 
SF – solid-follicular variant
According to the literature, the development of PTC with diffuse-sclerosing structure 
has been associated with previous radiation exposure [1,2,37,38]. However, studies of 
«post-Chernobyl» carcinomas did not confirm this notion as such tumors were observed in 
not more than in 7.0-9.0% cases and mostly in children [10,11,16].
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In less than 1% of cases, the Warthin-like variant (Table 4.4) was found in later periods 
(2000-2004 and 2005-2010, mostly in adults). Its distinctive feature is a profound 
intratumoral thyroiditis (Fig. 4.6). Tumors were represented by oxyphilic cells and generally 
had papillary or papillary-solid structure; they were also characterized by the very strong 
diffuse immunohistochemical reaction for thyroglobulin (Fig. 4.6 D) and TTF-1 (Fig. 4.6 
E). Referring the Warthin-like variant to PTC is justified by enlarged and cleared nuclei 
(Fig. 4.6 C). The proliferative activity of tumor cells (immunohistochemical reaction with 
anti-Ki67 antibodies) was not high, less than 5% (Fig. 4.6 F), which is, again, characteristic 
of PTC in general [3,4]. The lesions ranged in size from 5 to 42 mm, all of them were 
non-encapsulated.  Lymph   node metastases were identified  in 7 out of 19 cases (36.8%),
Figure 4.6. Warthin-like variant of papillary thyroid carcinoma. (A, B) Papillary-solid and 
papillary growth pattern, profound intratumoral thyroiditis. Tumors are represented by oxyphilic 
cells. Haematoxylin and eosin, original magnification x100. (C) Nuclear features of Warthin-like 
variant. Haematoxylin and eosin, original magnification x200. (D) Strong diffuse cytoplasmic 
staining for thyroglobulin, original magnification x100. (E) Strong nuclear reactivity for TTF-1, 
original magnification x100. (F) Focal nuclear reactivity for Ki67, original magnification x100. 
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but none showed distant metastases (Table 4.9). Our data are in agreement with the opinion 
of other authors [39] that these tumors behave similarly to conventional PTCs. The impact 
of radiation on the development of this subtype is not established yet. 
In two cases (female patients aged 26 and 27 years), an even more rare variant of PTC, 
the Cribriform-morular, was identified (0.1%). Tumors were represented by the nodule-
like lesions localized between markedly sclerosed stroma (Fig. 4.7 A, 4.7 B). An essential 
difference between this and other subtypes was the presence of numerous morulas (Fig. 
4.7 C, 4.7 D). Tumor areas had solid or follicular structure with the colloid being practically 
absent in all follicles. In the solid areas, cells were of polygonal shape; nuclei were more 
dense than in other subtypes and contained a small number of intranuclear inclusions. 
Immunohistochemical reaction with antithyroglobulin antibodies was practically negative, 
while the reaction with anti-TTF-1 antibodies was highly intensive and diffuse in tumor 
cell nuclei but virtually absent in the nuclei of the cells within morulas (Fig. 4.7 E). A 
highly intensive reaction to ß-catenin was revealed in the nuclei and cytoplasm of tumor 
cells; staining in morulas was rather weak and had a diffuse pattern (Fig. 4.7 F). Nuclei 
positive for Ki67 were rare both in tumor and in morular cells (Fig. 4.7 G); weakly positive 
for TP53 (p53) nuclei were detected in 3-5% of tumor and morular cells (Fig. 4.7 H). The 
described tumors fully correspond to the data available in the literature [3,4] not only by 
morphological characteristics, age and gender of patients, but also by the diagnosis of 
familial adenomatous polyposis (FAP) in these individuals as stated in their medical records. 
No impact of radiation on the development of this subtype of PTC has been found. 
The most aggressive variants according to the literature [1,3,4,37,40], the Tall-cell 
and Columnar-cell variants, were not observed among PTCs under study. In three cases 
in adults (0.3%), only isolated tall-cell areas were noted in the tumors with papillary-
trabecular architecture. Columnar-cell areas were detected in an adult patient only in one 
tumor (0.1%) which was, again, of papillary-trabecular structure. Such areas demonstrated 
pseudostratified columnar cells with subnuclear and supranuclear cytoplasmic vacuoles 
(Fig. 4.8 A). Thyroglobulin in such areas was expressed at the apical part of cells and in the 
narrowed fine intrapapillary space (Fig. 4.8 B); practically all nuclei of tumor cells expressed 
TTF-1 (Fig. 4.8 C), and only few (2-3%) expressed Ki67 (Fig. 4.8 D). The reaction with anti-
TP53 antibodies was negative. 
Further, we analyse three main subtypes of PTC (classic papillary, follicular, and solid 
variants) and tumors with mixed growth pattern for age and time related changes. 
In the first five years of a significant rise in thyroid cancer incidence (1990-1994), PTCs 
in children operated at under 15 years of age (127 out of 167 cases, 76.0%) were the most 
prevalent. 66.1% of these tumors had follicular and solid structure (Table 4.4). Of note, the 
follicular variant differed from that described in adults by more roundish nuclei and the 
presence of solid component (up to 20.0%) in all cases, commonly in the areas of intrathyroidal 
or extrathyroidal extension. Besides, in the tumors with mixed growth pattern (“mixed 
variant”) in this age group (Table 4.5), the prevalence of the solid-follicular architecture was 
significantly higher than those of other structural combinations (p<0.0018 vs papillary-
follicular; p<0.0058 vs papillary-solid, and p<0.0001 vs papillary-follicular-solid). 
Such architectural particularities of tumors in children prompted the introduction of 
the special solid-follicular “childhood variant” of PTC [38], which combines tumors of solid, 
follicular, and solid-follicular variants. 
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Figure 4.7. Cribriform-morular variant of papillary thyroid carcinoma. (A, B) Nodule-like lesions, 
marked stromal sclerosis. Haematoxylin and eosin, original magnification x10-panoramic; x50. (C, 
D) Numerous morulas and empty follicles. Haematoxylin and eosin, original magnification x50; 
x200. (E) Diffuse strong nuclear reactivity for TTF-1, original magnification x200. (F) Diffuse strong 
cytoplasmic and nuclear staining for ß-catenin in tumor cells; diffuse and weakly positive staining in 
morulas. Original magnification x200. (G) Focal nuclear reactivity for Ki67 in tumor and morular cells, 




Figure 4.8. Columnar-cell areas of papillary thyroid carcinoma. (A) Papillary-trabecular growth 
pattern, prominent subnuclear vacuoles, and moderate pseudostratification. Haematoxylin and 
eosin, original magnification x100. (B) Strong apical cytoplasmic thyroglobulin staining, original 
magnification x100. (C) Diffuse strong nuclear reactivity for TTF-1, original magnification x100. (D) 
Focal nuclear reactivity for Ki67, original magnification x100. 
During the first decade after Chernobyl, tumors of “childhood variant” accounted for 
up to 80% in patients operated at the age under 15 years in Ukraine and Belarus. These 
PTCs were characterized by marked intrathyroidal and extrathyroidal extension, invasion 
of lymphatic and blood vessels, and very frequent regional metastases [11,17,18,20,41,42]. 
It should be noted that such a “combined” solid-follicular variant of PTC was much more 
prevalent among children of Ukraine and Belarus affected by the Chernobyl accident 
compared to nonexposed children of England and Wales [11,17]. 
In addition, it has been established in Ukraine that the relative risk of development of 
“childhood variant” PTC was increasing with thyroid exposure dose: 2.2-fold at the dose 
0.05 to 0.2 Gy, 5.2-fold at 0.2 to 1.0 Gy, and 6.7-fold at >1.0 Gy. Overall, the relative risk of 
development of such tumors at thyroid exposure dose exceeding 0.05 Gy was 3.7 [43]. 
In children of Russia, the follicular variant of PTC [44] was most common in post-
Chernobyl years. No correlation between morphological structure and thyroid exposure 
dose was found [14]. 
79
Thyroid cancer pathology in Ukraine after Chernobyl
It has been claimed that the presence of a marked solid component determined the 
aggressiveness of biological behaviour of PTC in children [16,17,18,20,38,45,46].  In this 
context, of interest are data obtained later by a group of experts-pathologists (which also 
included representatives of Ukraine, Belarus and Russia) in the framework of an international 
project for establishment of the Chernobyl Tissue Bank. The group performed an analysis 
of the histological structure of PTCs and their latency [47]. Three groups of children have 
been selected differing by age at exposure, age at surgery, and by the period of latency 
(defined as time interval between the Chernobyl accident and date of surgery). A significant 
difference was found in the prevalence of less differentiated (solid) and more differentiated 
(papillary and follicular) structural components depending on latency. PTCs developing after 
a short latency were characterized by the more prominent solid component and by more 
pronounced intrathyroidal and extrathyroidal extension as compared to those occurring after 
a longer latency. The latter tumors generally displayed papillary-follicular growth pattern and 
peritumoral fibrosis, which are usually considered to be less aggressive pathological features. 
It needs to be emphasized that PTCs with architecturally less differentiated solid areas 
should not be erroneously assimilated into the poorly differentiated thyroid tumors group 
[1,3,4,25,30,37,48] as these are different in both histological structure and prognosis. 
The same group of pathologists proposed later that the abundance of the solid 
component in “post-Chernobyl” childhood PTCcould also be influenced by a moderate 
iodine deficiency observed in the affected countries as compared to England and Wales, 
and especially to Japan [49].
Since 25 years have already passed after the Chernobyl accident, children who had 
experienced the strongest impact of radioactive iodine from fallout have already moved 
over to the age category of “adults” for a long time. Therefore, it appears inappropriate to 
continue using the term “childhood variant” today; for this reason, our analysis was based on 
generally accepted PTC subtypes. The highest percentage of tumors with a solid structure, 
which, as mentioned above, are architecturally less differentiated, was observed in children 
(21.0%). This is in line with the results of other studes of radiation-induced or sporadic PTC 
in children [3,4,25,29,46]. The frequency of tumors with classic papillary structure was, on 
the contrary, the highest in adults (33.7%), with a highly significant age trend (р=0.0001). 
The ratio of PTC subtypes significantly changed with time after Chernobyl, i.e. with 
increasing period of latency. In all age groups the percentage of tumors with solid structure 
was gradually decreasing while that of classic papillary and, especially, mixed structure was 
increasing (Table 4.4). Similarly to the age-related changes, time-related linear trends were 
also highly significant (р=0.0001). Besides, in all age groups combined, the frequency of the 
solid variant decreased from 26.6% in the first period of observation (1990-1994) to 6.5% in 
the last period (2005-2010) while the frequency of the classic papillary variant increased from 
9.0 to 32.0%. Structural combinations of the mixed variant also markedly changed with time 
(Table 4.5). The frequency of tumors with solid-follicular structures gradually decreased (from 
64.7% in 1990-1994 to 28.7% in 2005-2010), and the percentage of tumors with papillary-
follicular structure increased (from 17.6% в 1990-1994 to 46.6% in 2005-2010).
Invasive features of PTCs under study (extrathyroidal extension to soft tissues adjacent 
to the thyroid, regional and distant metastases), and their relationship to tumor size and 
multifocality as assessed according to the seventh edition of TNM Classification [50], also 




Size of papillary thyroid carcinomas and the prevalence of lymph node and distant 
metastases in patients born before Chernobyl
1st period: surgery in 1990-1994
pT/tumor size 
                                      All age groups
N0 N1a N1b Total pT M0 M1
number number number number % number number
pT1a (up to 5 mm) 1     1 0.5 1  
pT1a (6-10 mm) 3     3 1.8 3  
pT1am (1-5 mm)              
pT1am (6-10 mm)              
pT1b (11-20 mm) 17 6   23 13.8 23  
pT1bm (11-20 mm)             1
pT2 (21-40 mm) 23 4 2 29 17.4 28 1
pT2m (21-40 mm)              
pT3 (>40 mm)* 8 2 2 12 7.2 11  
pT3m (>40 mm)*             30
pT3 (any size)** 11 13 61 85 50.9 55 13
pT3m (any size)**     14 14 8.4 1  
Total 63 (37.7%) 25 (15.0%) 79 (47.3%) 167 100 122 (73.1%) 45 (26.9%)
2nd period: surgery in 1995-1999
pT/tumor size 
                                      All age groups
N0 N1a N1b Total pT M0 M1
number number number number % number number
pT1a (up to 5 mm)              
pT1a (6-10 mm) 16 1   17 4.7 17  
pT1am (1-5 mm)              
pT1am (6-10 mm)              
pT1b (11-20 mm) 70 22 4 96 26.3 95 1
pT1bm (11-20 mm) 3     3 0.8 3  
pT2 (21-40 mm) 28 14 3 45 12.3 45  
pT2m (21-40 mm) 2     2 0.5 2  
pT3 (>40 mm)* 10 2 1 13 3.6 13  
pT3m (>40 mm)*              
pT3 (any size)** 39 34 92 165 45.2 115 50
pT3m (any size)**     24 24 6.6 3 21
Total 168 (46.0%) 73 (20.0%) 124 (34.0%) 365 100 293 (80.3%) 72 (19.7%)
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Continuation of Table 4.6
3rd period: surgery in 2000-2004
pT/tumor size 
                                      All age groups
N0 N1a N1b Total pT M0 M1
number number number number % number number
pT1a (up to 5 mm) 24     24 3.3 24  
pT1a (6-10 mm) 40 6 2 48 6.6 48  
pT1am (1-5 mm) 1 1   2 0.3 2  
pT1am (6-10 mm) 6 2 1 9 1.2 9  
pT1b (11-20 mm) 181 51 17 249 34.0 247 2
pT1bm (11-20 mm)     2 2 0.3 1 1
pT2 (21-40 mm) 75 24 13 112 15.3 110 2
pT2m (21-40 mm) 7 1   8 1.0 8  
pT3 (>40 mm)* 20 1 1 21 2.9 21  
pT3m (>40 mm)* 1     2 0.3 2  
pT3 (any size)** 56 42 128 226 30.9 196 30
pT3m (any size)** 5 6 18 29 3.9 23 6
Total 416 (56.8%) 134 (18.3%) 182 (24.9%) 732 100 691 (94.4%) 41 (5.6)
4th period: surgery in 2005-2010
pT/tumor size 
                                      All age groups
N0 N1a N1b Total pT M0 M1
number number number number % number number
pT1a (up to 5 mm) 79 1 3 83 6.8 83  
pT1a (6-10 mm) 173 24 9 206 17.0 206  
pT1am (1-5 mm) 11 1 1 13 1.1 13  
pT1am (6-10 mm) 30 6 2 38 3.1 38  
pT1b (11-20 mm) 228 62 20 310 25.5 310  
pT1bm (11-20 mm) 32 8 3 43 3.6 43  
pT2 (21-40 mm) 150 25 16 191 15.7 189 2
pT2m (21-40 mm) 16 3 6 25 2.1 25  
pT3 (>40 mm)* 44 11   55 4.5 55  
pT3m (>40 mm)* 9 2   11 0.9 11  
pT3 (any size)** 70 34 88 192 19.8 176 16
pT3m (any size)** 13 8 26 47 3.9 43 4
Total 855 (70.4%) 185 (15.3%) 174 (14.3%) 1214 100 1192 (98.2%) 22 (1.8%)
*- no extrathyroidal extension; ** - extrathyroidal extension 
While during the first period of observation (1990-1994), the signs of extrathyroidal 
extension were identified in 59.3% cases, their frequency gradually decreased 
with increasing latency to 23.7% in 2005-2010. Such a tendency was also noted in 
the analysis of the frequency of regional and distant metastases. The percentage 
of cases with metastases to lymph nodes decreased from 62.3 to 29.6%, and that of 
distant metastases to the lung (detected during postoperative treatment of patients with 
radioiodine), decreased from 26.9 to 1.8%. All the above changes were characterized by 
significantly descending linear trends (р=0.0001).
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The frequency of tumor foci detected in the form of separate lesions in contralateral 
lobe or sometimes in the affected lobe as well (Tm) in the first three time periods, i.e. during 
1990-2004, practically did not differ (Table 4.7): 8.4% (14/167), 7.9% (29/365), and 7.1% 
(52 cases out of 732). Only in 2005-2010, the frequency of multifocal tumors significantly 
increased as compared with the first period of time (р=0.0309). 
Also, it should be noted that before 2000, the “additional” tumoral foci which did not 
differ structurally from the main tumor were mostly seen among cases of “aggressive” 
PTCs sized more than 10 mm with signs of extrathyroidal extension and regional as well as 
distant metastases (Table 4.6, 4.7 and Fig. 4.9). 
Figure 4.9. Multifocal papillary thyroid carcinoma. (A) Nonencapsulated main tumor sized 
15 mm in the left lobe, follicular variant with the solid growth pattern. Haematoxylin and eosin, 
original magnification x10. (B) Multifocal lesion in the right lobe sized 5 mm with the solid-follicular 
structure. Haematoxylin and eosin, original magnification x20. 
In 2000-2004, and especially in 2005-2010, different foci of multifocal tumors were 
characterized by variations in size, including microtumors (Table 4.7), by the degree of 
encapsulation, and by structural and invasive features. For an instance, in the same patient, 
there might be an encapsulated tumor of mixed structure sized more than 10 mm, and a 
separate nonencapsulated microtumor of mixed structure in one lobe (Fig. 4.10 A-E). In the 
contralateral lobe there might be, again, an encapsulated tumor of mixed structure sized 
more than 10 mm, and a nonencapsulated oxyphilic-cell tumor of the solid structure with 
signs of marked intratumoral and peritumoral thyroiditis (Fig. 4.10 F-H). In this example 
tumors are likely to be multiple PTCs developing independently.
Invasive features of PTCs also depended on patients’ age. The highest frequency of 
tumors displaying intrathyroidal and extrathyroidal extension, vascular invasion, regional 
metastases to cervical lymph nodes and distant metastases to the lung was found in 
children (Table 4.8). For all these features, significantly descending linear age trends were 
found (р=0.0001). 
Morphological signs of aggressiveness (extrathyroidal extension, vascular invasion, 
regional metastases) were revealed in all histological subtypes, mostly in nonencapsulated 
tumors (Table 4.9). In encapsulated PTCs (Fig. 4.11), tumor capsule invasion was observed 
in most cases, intrathyroidal extension in not more than 40.0%, and was limited only to 
isolated tumoral foci outside the tumor in adjacent thyroid tissue (Fig. 4.11 D). 
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Figure 4.10. Multiple papillary thyroid carcinomas revealed in the same patient. (A) Encapsulated 
tumor in the right lobe sized 22 mm with the mixed growth pattern. Haematoxylin and eosin, original 
magnification x10-panoramic. (B) High-power image of the same tumor. Macrofollicular growth 
pattern. Haematoxylin and eosin, original magnification x100. (C) High-power image of the same 
tumor. Microfollicular growth pattern. Haematoxylin and eosin, original magnification x100. (D) 
High-power image of the same tumor, different area. Solid-follicular component between fibrotic 
stroma. Haematoxylin and eosin, original magnification x200. (E) Nonencapsulated tumor in the right 
lobe sized 6 mm with the solid-follicular growth pattern and small papillary loci. Marked stromal fibrosis. 
Haematoxylin and eosin, original magnification x20-panoramic. (F) Encapsulated tumor in the left lobe 
sized 11 mm with the papillary-solid growth pattern. Evident tumor capsule invasion. Haematoxylin 
and eosin, original magnification x20. (G) Nonencapsulated oxyphilic-cells tumor in the left lobe sized 
9 mm with the solid and trabecular growth pattern. Evident intratumoral and peritumoral thyroiditis. 
Haematoxylin and eosin, original magnification x20. (H) High-power of the same tumor. Intranuclear 
pseudoinclusions in oxyphilic tumor cells. Haematoxylin and eosin, original magnification x200.
84
Chapter 4 
Extrathyroidal extension was registered only in 1.2% cases in adults among fully 
encapsulated tumors with subcapsular localization; regional metastases were found in 
isolated cases in each age group. Regional lymph node metastases in adults were more 
frequently seen in the classic papillary variant than in follicular or solid variants (Table 
4.10). A higher rate of lymph node metastases in encapsulated classical papillary thyroid 
carcinomas was also reported in an independent study [51]. No distant metastases to the 
lung in patients with encapsulated РТС were found during the whole period of observation 
(Table 4.10). This is in excellent agreement with the opinion of J. Rosai: “Papillary thyroid 
carcinoma totally surrounded by a capsule may still be associated with nodal metastases, 
but the incidence of distant metastases or tumor death is nearly zero” [4]. 
Table 4.7 




Children aged up to 14 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
up to 5 - - - - - - - - - -
6-10 - - - - - - - - - -
11-20 3 23.1 1 11.1 - - - - 4 18.2
21-30 4 30.7 - - - - - - 4 18.2
31-40 1 7.7 - - - - - - 1 4.5
41-50 3 23.1 1 11.1 - - - - 4 18.2
51-60 1 7.7 4 44.5 - - - - 5 22.7
>60 1 7.7 3 33.3 - - - - 4 18.2
Total 13 100 9 100  0  - - 22  100
Adolescents aged from 15 to 18 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
up to 5 - - - - - - - - - -
6-10 - - - - 1 10.0 - - 1 5.2
11-20 - - 4 50.0 4 40.0 - - 8 42.1
21-30 - - 1 12.5 3 30.0 - - 4 21.1
31-40 1 100 2 25.0 1 10.0 - - 4 21.1
41-50 - - 1 12.5 1 10.0 - - 2 10.5
51-60 - - - - - - - - - -
>60 - - - - - - - - - -
Total 1 100 8 100 10 100 - - 19 100
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Continuation of Table 4.7
Adults aged from 19 to 42 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
up to 5 - - - - 2 4.8 15 8.5 17 7.4
6-10 - - - - 11 26.2 44 24.8 55 23.8
11-20 - - 5 41.7 10 23.8 62 35.0 77 33.3
21-30 - - 2 16.7 8 19.0 21 11.9 31 13.4
31-40 - - - - 2 4.8 17 9.6 19 8.2
41-50 - - - - 5 11.9 10 5.6 15 6.5
51-60 - - 1 8.3 4 9.5 4 2.3 9 3.9
>60 - - 4 33.3 - - 4 2.3 8 3.5
Total 0 - 12 100 42 100 177 100 231 100
All age groups
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
up to 5 - - - - 2 3.8 15 8.5 17 6.3
6-10 - - - - 12 23.1 44 24.8 56 20.6
11-20 3 21.4 10 34.5 14 26.9 62 35.0 89 32.7
21-30 4 28.7 3 10.3 11 21.2 21 11.9 39 14.3
31-40 2 14.3 2 6.9 3 5.8 17 9.6 24 8.8
41-50 3 21.4 2 6.9 6 11.5 10 5.6 21 7.7
51-60 1 7.1 5 17.3 4 7.7 4 2.3 14 5.1
>60 1 7.1 7 24.1 - - 4 2.3 12 4.5
Total 14 100 29 100 52 100 177 100 272 100
In nonencapsulated PTCs, the most pronounced intrathyroidal extension was noted 
in the diffuse-sclerosing variant (Fig. 4.5A) apparently stemming from its definition. For 
patients of all ages with diffuse sclerosing variant of PTC, a high frequency of extrathyroidal 
extension and metastases to lymph nodes was registered as well (Table 4.9). Metastases 
most commonly had papillary-solid structure with marked signs of oxyphilic-cell and 
squamous-cell metaplasia (Fig. 4.12). In children and adolescents with diffuse sclerosing 
variant of PTC, distant metastases to the lung were also found in 23.5 and 25.0% cases, 
respectively. These data additionally attest to the aggressive behaviour of this variant of 
PTC [1,3,4,29], but, as already mentioned above, the small number of cases does not allow 
establishing a link between such a tumor structure and exposure to Chernobyl fallout. 
Our review of the three main subtypes of PTC (classic papillary, follicular and solid) 
and of the mixed-type PTC shows that the identification of the (formerly) “childhood 
variant” [17,38] which combines - as already pointed out - tumors with solid, follicular, 
and solid-follicular structures, was pathologically justified. All signs of aggressiveness: 
vascular invasion, multifocality, extrathyroidal extension, regional lymph node and distant 
metastases were most pronounced namely in children who had nonencapsulated tumors 
with such structure (Table 4.9). 
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Figure 4.11. Fully encapsulated papillary thyroid carcinomas. (A) Tumor with the follicular 
growth pattern. Evident tumor capsule invasion and central fibrosis. Haematoxylin and eosin, original 
magnification x20-panoramic. (B) Tumor with the solid-follicular growth pattern. Haematoxylin and 
eosin, original magnification x20-panoramic. (C) Tumor with the papillary growth pattern. Tumor capsule 
invasion. Haematoxylin and eosin, original magnification x50. (D) Tumor with solid-follicular growth 
pattern. Intrathyroidal extension of the tumor. Haematoxylin and eosin, original magnification x50.
Figure 4.12. Lymph node metastases of the diffuse-sclerosing variant of papillary thyroid 
carcinomas. (A) Papillary-solid growth pattern. Haematoxylin and eosin, original magnification x10-
panoramic. (B) Papillary growth pattern. Cystic changes, numerous psammoma bodies, extra-lymph 
node extension. Haematoxylin and eosin, original magnification x20. (C) Papillary-solid growth 
pattern. Evident oxyphilic-cell metaplasia. Haematoxylin and eosin, original magnification x20. 
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Table 4.8 
Invasive properties of papillary thyroid carcinoma in patients born before Chernobyl
Subtype 
(number)








extension Regional mts Distant mts
number % number % number % number % number % number % number %
PV (30) 21 70.0 20 66.7 1 3.3 - - 14 46.7 16 53.3 4 13.3
FV (65) 32 49.2 40 61.5 25 38.5 4 6.2 43 66.2 38 58.5 21 32.3
SV (57) 33 57.9 43 75.4 23 40.4 8 12.3 50 87.7 45 78.9 19 33.3
PFV (16) 8 56.0 9 56.3 1 6.3 1 6.3 8 50.0 11 68.8 4 25.0
PSV (11) 5 45.5 5 45.5 2 18.2 1 9.1 4 36.4 9 81.8 1 9.1
PSFV (3) 2 66.7 1 33.3 - - - - 2 66.7 3 100 - -
SFV (73) 50 68.5 54 74.0 31 42.5 8 11.0 58 79.5 53 72.6 23 31.5
DSV (17) 17 100 17 100 - - - - 7 41.2 9 52.9 4 23.5
Warthin (0) - - - - - - - - - - - - - -
Cribriform (0) - - - - - - - - - - - - - -
Total (272) 168 61.8 189 69.5 83 30.5 22 8.1 186 68.4 184 67.6 76 27.9








extension Regional mts Distant mts
number % number % number % number % number % number % number %
PV (48) 26 54.2 22 45.8 3 6.3 3 6.3 18 37.5 22 45.8 5 10.4
FV (47) 24 51.1 21 44.7 11 23.4 1 2.1 19 40.4 22 46.8 6 12.8
SV (24) 17 70.8 11 45.8 11 45.8 3 12.5 15 62.5 10 41.7 4 16.7
PFV (38) 17 44.7 13 34.2 5 13.2 4 10.5 16 42.1 20 52.6 5 13.2
PSV (18) 12 66.7 6 33.3 2 11.1 3 16.7 9 50.0 13 72.2 4 22.2
PSFV (5) 3 60.0 3 60.0 1 20.0 - - 3 60.0 5 100 2 40.0
SFV (40) 26 65.0 20 76.9 9 22.5 5 12.5 21 52.5 22 55.0 12 30.0
DSV (4) 4 100 4 100 - - - - 4 100 4 100 1 25.0
Warthin (1) - - - - - - - - - - - - - -
Cribriform (0) - - - - - - - - - - - - - -
Total (225) 129 57.3 100 44.4 42 18.7 19 8.4 105 46.7 118 52.4 39 17.3
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Continuation of Table 4.8
Subtype  
(number)








extension Regional mts Distant mts
number % number % number % number % number % number % number %
PV (667) 200 30.0 203 30.4 29 4.3 69 10.3 133 19.9 225 33.7 10 1.5
FV (332) 100 30.1 58 17.5 49 14.8 38 11.4 63 19.0 79 23.6 8 2.4
SV (118) 40 33.9 39 33.1 37 31.4 17 14.4 41 34.7 35 29.7 6 5.1
PFV (422) 170 40.3 129 30.6 47 11.1 45 10.7 136 32.2 192 45.5 19 4.5
PSV (143) 61 42.7 65 45.5 21 14.7 20 14.0 47 32.9 59 41.3 9 6.3
PSFV (49) 25 51.0 20 41.7 16 32.7 7 14.3 14 28.6 17 34.7 4 8.2
 SFV (223) 65 29.1 50 22.4 49 22.0 32 14.3 48 21.5 63 23.8 9 4.0
DSV (6) 6 100 6 100 - - - - 5 83.3 6 100 - -
Warthin (19) 5 26.3 6 31.6 3 15.8 3 15.8 4 21.1 7 36.8 - -
Cribriform (2) 2 100 1 50.0 1 50.0 - - - - 1 50.0 - -
Total (1981) 674 34.0 577 29.1 252 12.7 231 11.7 491 24.8 674 34.0 65 3.3
Table 4.9 
Invasive properties of nonencapsulated and partly encapsulated papillary thyroid carcinoma in patients born before Chernobyl
Subtype 
(number)








extension Regional mts Distant mts
number % number % number % number % number % number % number %
PV (26) 18 69.2 17 65.4 1 3.8 - - 14 53.8 15 57.7 4 15.4
FV (57) 31 54.4 38 66.7 21 36.8 4 7.0 43 75.4 37 64.9 21 36.8
SV (54) 31 57.4 42 77.8 22 40.7 8 14.8 50 92.6 44 81.5 19 35.2
PFV (14) 7 50.0 9 64.3 1 7.1 1 7.1 8 57.1 10 71.4 4 28.6
PSV (11) 5 45.5 5 45.5 2 18.2 1 9.1 4 36.4 9 81.8 1 9.1
PSFV (3) 2 66.7 1 33.3 - - - - 2 66.7 3 100 - -
SFV (69) 49 71.0 53 71.0 30 43.5 8 11.6 58 84.1 53 76.8 23 33.3
DSV (17) 17 100 17 100 - - - - 7 41.2 9 52.9 4 23.5
Warthin (0) - - - - - - - - - - - - - -
Cribriform (0) - - - - - - - - - - - - - -
Total (251) 160 63.7 182 72.5 77 30.7 22 8.8 186 74.1 180 71.7 76 30.3
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extension Regional mts Distant mts
number % number % number % number % number % number % number %
PV (40) 22 55.0 21 52.5 3 7.5 3 7.5 18 45.0 20 50.0 5 12.5
FV (40) 21 52.5 19 47.5 11 27.5 1 2.5 19 47.5 21 52.5 6 15.0
SV (23) 16 69.5 10 43.5 11 47.8 3 13.0 15 65.2 10 43.5 4 17.4
PFV (31) 15 48.4 12 38.7 5 16.1 3 9.7 16 51.6 20 64.5 5 16.1
PSV (15) 11 73.3 6 40.0 2 13.3 3 20.0 9 60.0 13 86.7 4 26.7
PSFV (5) 3 60.0 3 60.0 1 20.0 - - 3 60.0 5 100 2 40.0
SFV (31) 23 74.2 18 58.1 7 22.6 5 16.1 21 67.7 22 71.0 12 38.7
DSV (4) 4 100 4 100 - - - - 4 100 4 100 1 25.0
Warthin (1) - - - - - - - - - - - - - -
Cribriform (0) - - - - - - - - - - - - - -
Total (190) 115 60.5 93 48.9 40 21.1 18 9.5 105 55.3 115 60.5 39 20.5








extension Regional mts Distant mts
number % number % number % number % number % number % number %
PV (499) 145 29.1 170 34.1 21 4.2 57 11.4 129 25.9 210 42.1 10 2.0
FV (178) 73 41.0 48 27.0 24 13.4 16 9.0 63 35.4 72 40.4 8 4.5
SV (74) 33 44.6 36 48.6 24 32.4 13 32.4 40 54.1 33 44.6 6 8.1
PFV (336) 134 39.9 113 33.6 37 11.0 36 10.7 136 40.5 185 55.0 19 5.7
PSV (128) 53 41.4 61 47.7 16 12.5 20 15.6 45 35.2 58 45.3 9 7.0
PSFV (33) 18 54.5 17 51.5 13 39.4 4 12.1 14 42.4 17 51.5 4 12.1
SFV (124) 45 36.3 46 37.1 24 19.4 24 19.4 48 38.7 52 41.9 9 7.3
DSV (6) 6 100 6 100 - - - - 5 83.3 6 100 - -
Warthin (19) 5 26.3 6 31.6 3 15.8 3 15.8 4 21.1 7 36.8 - -
Cribriform (2) 2 100 1 50.0 1 50.0 - - - - 1 50.0 - -
Total (1399) 514 36.7 504 36.0 163 11.7 173 12.4 484 34.6 641 45.8 65 4.6




Invasive properties of fully encapsulated papillary thyroid carcinoma in patients born before Chernobyl
Subtype 
(number)










extension Regional mts Distant mts
number % number % number % number % number % number % number % number %
PV (4) 4 100 3 75.0 3 75.0 - - - - - - 1 25.0 - -
FV (8) 7 87.5 1 12.5 2 25.0 4 50.0 - - - - 1 12.5 - -
SV (3) 3 100 2 66.7 1 33.8 1 33.3 - - - - 1 33.3 - -
PFV (2) 2 100 1 50.0 - - - - - - - - 1 50.0 - -
PSV (0) - - - - - - - - - - - - - - - -
PSFV (0) - - - - - - - - - - - - - - - -
SFV (4) 1 25.0 1 25.0 1 25.0 1 25.0 - - - - - - - -
Total (21) 17 81.0 8 38.1 7 33.3 6 28.6 0 - 0 - 4 19.0 0 -
Subtype 
(number)










extension Regional mts Distant mts
number % number % number % number % number % number % number % number %
PV (8) 8 100 4 50.0 1 12.5 - - - - - - 2 25.0 - -
FV (7) 7 100 3 42.9 2 28.6 - - - - - - 1 14.8 - -
SV (1) 1 100 1 100 1 100 - - - - - - - - - -
PFV (7) 7 100 2 28.6 1 14.3 - - 1 14.3 - - - - - -
PSV (3) 3 100 1 33.3 - - - - - - - - - - - -
PSFV (0) - - - - - - - - - - - - - - - -
SFV (9) 9 100 3 33.3 2 22.2 2 22.2 - - - - - - - -
Total (35) 35 100 14 40.0 7 20.0 2 5.7 1 2.9 0 - 3 8.6 0 -
Subtype 
(number)










extension Regional mts Distant mts
number % number % number % number % number % number % number % number %
PV (168) 167 99.4 55 32.7 33 19.6 8 4.8 12 7.1 4 2.4 15 8.9 - -
FV (154) 129 83.8 27 17.5 10 6.5 25 16.2 22 14.3 - - 7 4.5 - -
SV (44) 39 88.6 7 15.9 3 6.8 13 29.5 4 9.1 1 2.3 2 4.5 - -
PFV (86) 82 95.3 36 41.9 16 18.6 10 11.6 9 10.5 - - 7 8.1 - -
PSV (15) 13 86.7 8 53.3 4 26.7 5 33.3 - - 2 13.3 1 6.7 - -
PSFV (16) 14 87.5 7 43.8 3 18.8 3 18.8 3 18.8 - - - - - -
SFV (99) 82 82.8 20 20.2 4 4.0 25 25.3 8 8.1 - - 1 1.0 - -
Total (582) 531 91.2 160 27.5 73 12.5 89 15.3 58 10.0 7 1.2 33 5.7 0 -
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By contrast, in adolescents and adults with tumors of such structural “combination”, no 
signs of the higher aggressiveness were found. This may probably be due to the fact that the 
architecture of the follicular variant in adolescents and adults differs from that in children. 
In older patients, the solid component is absent or confined to very small foci in the areas 
of invasive growth. On the other hand, when combining tumors with the solid and solid-
follicular structure in adolescents and adults, the frequency of extrathyroidal extension was 
significantly higher (р<0.05) as compared to other subtypes: in adolescents 66.7% (36/54 
cases of the solid and solid-follicular subtypes) vs 50.7% (69/136 cases of other subtypes), 
and 44.4% (88/198 cases of the solid and solid-follicular subtypes) vs 33.0% (396/1201 
cases of other subtypes) in adults. In addition, in the adult group, such a pooling showed 
a significantly higher frequency, as compared to other subtypes, of vascular invasion 
(р<0.001), multifocality (р<0.01) and distant metastases (Table 4.9). Thus, despite the finding 
that the prevalence of РТСs with the solid and solid-follicular structure was significantly 
declining with increasing patients’ age and latency, morphological signs of aggressiveness 
in such tumors were still preserved.
According to the WHO classification [5], papillary microcarcinoma represented by the 
tumors sized up to 10 mm is considered to be an independent subtype. We already noted 
that the prevalence of microcarcinomas in the groups under study was significantly rising 
with increasing age of patients and latency (Table 4.3), i.e. time elapsed after Chernobyl. 
The presence of the “full” capsule (Fig. 4.13 A) was found in 20.8% tumors sized up to 5 
mm (26/125) and in 22.4% (83/170) sized from 6 to 10 mm, i.e. most “small” tumors were 
nonencapsulated (Fig. 4.13 B-C). 
Figure 4.13. Papillary microcarcinomas. (A) Fully encapsulated tumor sized 7 mm with the 
papillary growth pattern. Haematoxylin and eosin, original magnification x20-panoramic. (B) 
Nonencapsulated tumor sized 7 mm with the solid growth pattern. Tumoral extension to the thyroid 
capsule and adjacent thyroid tissue. Haematoxylin and eosin, original magnification x20. (C) Tumor 
sized 5 mm with the papillary-solid growth pattern. Extrathyroidal extension, marked intratumoral 
fibrosis. Haematoxylin and eosin, original magnification x10. 
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Microcarcinomas, similarly to large size РТСs, may have different structure: classic 
papillary (Fig. 4.13 A), follicular, solid (Fig. 4.13 B) or mixed (Fig. 4.13 C). No statistically 
significant predominance of any histological variant – among both encapsulated and 
nonencapsulated tumors – was found in microcarcinomas (Table 4.11, 4.12). 
The invasive features of microcarcinoma depended on tumor size and encapsulation. 
Encapsulated tumors sized up to 5 mm, regardless of architecture, were minimally invasive 
in all 26 cases. Although tumor cells might display signs of invasion into the tumor capsule, 
not  a single case showed spread outside its limits; there were no signs of vascular invasion 
or metastases to lymph nodes. In three cases (11.5%) diagnosed during the last period of 
observation microtumors were multiple, as was mentioned above.
Table 4.11
Subtypes of fully encapsulated micro-PTC in patients born before Chernobyl 
sized from 1 to 5 mm
Subtype
                                                        All age groups 
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
PV - - - - 2 40.0 7 33.3 9 34.7
FV - - - - 1 20.0 7 33.3 8 30.8
SV - - - - - - 1 4.8 1 3.8
PFV - - - - - - 2 9.5 2 7.7
PSV - - - - 1 20.0 1 4.8 2 7.7
PSFV - - - - - - 1 4.8 1 3.8
SFV - - - - 1 20.0 2 9.5 3 11.5
Warthin - - - - - - - - - -
Cribriform - - - - - - - - - -
Total - - - - 5 100 21 100 26 100
sized from 6 to 10 mm 
 
                                                        All age groups
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
PV - - 3 30.0 5 35.7 15 25.0 23 27.4
FV - - 2 20.0 4 28.6 12 20.0 18 21.4
SV - - 1 10.0 - - 9 15.0 10 11.9
PFV - - 2 20.0 3 21.5 10 16.7 15 17.8
PSV - - 2 20.0 1 7.1 2 3.3 5 6.0
PSFV - - - - - - 5 8.3 5 6.0
SFV - - - - 1 7.1 7 11.7 8 9.5
Warthin - - - - - - - - - -
Cribriform - - - - - - - - - -
Total - - 10 100 14 100 60 100 84 100
Encapsulated microcarcinomas sized from 6 to 10 mm were also minimally invasive in 
general. However, in two cases out of 84 (2.4%), in the presence of follicular or papillary-
follicular structures, there were metastases to lymph nodes (N1a); in 7 cases (8.3%) signs of 
lymphatic invasion, and in 7 cases (8.3%) multiple microtumors were seen. 
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Nonencapsulated microcarcinomas, similarly to the tumors of larger size, were 
characterized by the more pronounced invasive features as compared to encapsulated ones. 
Even very small tumors (up to 5 mm) of the follicular, solid, and mixed structure displayed 
signs of moderate intrathyroidal spread in 11.1% cases (11/99), lymphatic invasion in 8.1% 
(8/99), vascular invasion in 1.0% (1/99), extrathyroidal extension in 2.0% (2/99, Fig. 4.13C), 
and metastases to lymph nodes (N1a) in 6.1% of cases (6/99). 
Table 4.12
Subtypes of nonencapsulated and partly encapsulated micro-PTC  
in patients born before Chernobyl
       sized from 1 to 5 mm
Subtype All age groups
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
PV 1 100 - - 7 33.3 10 13.0 18 18.2
FV - - - - 6 28.5 17 22.1 23 23.2
SV - - - - 1 4.8 9 11.7 10 10.1
PFV - - - - 3 14.3 13 16.9 16 16.2
PSV - - - - 1 4.8 9 11.7 10 10.1
PSFV - - - - 1 4.8 - - 1 1.0
SFV - - - - 2 9.5 18 23.3 20 20.2
Warthin - - - - - - 1 1.3 1 1.0
Cribriform - - - - - - - - - -
Total 1 100 - - 21 100 77 100 99 100
sized from 6 to 10 mm 
 
All age groups
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
PV - - 2 18.2 21 38.2 75 34.7 98 34.3
FV 1 25.0 1 9.1 8 14.5 28 13.0 38 13.3
SV 2 50.0 1 9.1 1 1.8 10 4.6 14 4.9
PFV - - 2 18.2 15 27.3 47 21.8 64 22.4
PSV - - 2 18.2 5 9.1 26 12.0 33 11.5
PSFV - - - - - - 9 4.2 9 3.1
SFV 1 25.0 3 27.2 5 9.1 20 9.2 29 10.1
Warthin - - - - - - 1 0.5 1 0.4
Cribriform - - - - - - - - - -
Total 4 100 11 100 55 100 216 100 286 100
Invasiveness of the tumors sized from 6 to 10 mm was significantly higher compared 
to that of microcarcinomas sized up to 5 mm: intrathyroidal extension was observed in 
22.0% (63 out of 286 cases, р=0.0178); lymphatic invasion in 24.8% (71/286, р=0.0003); 
extrathyroidal extension in 16.1% (46/286, р=0.0001); lymph node metastases in 23.3% 
(67/286, р=0.0001). However, all these were significantly lower than in nonencapsulated 
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carcinomas sized more than 10 mm for all age groups (Table 4.9). It should be emphasized 
that not in a single case of PTC sized up to 10 mm distant metastases to the lung were 
detected in the course of postoperative follow-up of patients. 
In Belarus, by contrast with Ukraine, the prevalence of post-Chernobyl microcarcinomas 
was much higher: 39.2% just in children operated on at the age under 15 years [52,53]; 
in some cases distant metastases to the lung were identified [54]. Thus, tumor size alone 
cannot be a determinant of the choice of treatment tactics. 
Table 4.13 
Concomitant thyroid diseases in patients with micro-PTC born before Chernobyl
sized from 1 to 5 mm
Pathology
All age groups
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
FTC - - - - - - - - - -
MTC - - - - - - - - - -
FA - - - - 5/26 19.2 19/98 19.4 24/125 19.2
Nodule - - - - 6/26 23.1 15/98 15.4 21/125 16.8
MNG 1/1 - - - 4/26 15.4 18/98 18.4 23/125 18.4
Graves’ - - - - 4/26 15.4 22/98 22.4 26/125 20.8
Chronic 
thyroiditis - - - - 4/26 15.4 6/98 6.1 10/125 8.0
Total 1/1 - 0  - 23/26 88.5 80/98 81.6 104/125 83.2
sized from 6 to 10 mm
All age groups 
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
FTC - - - - - - - - - -
MTC - - - - - - - - - -
FA - - - - 8/69 11.6 16/276 5.8 24/370 6.5
Nodule - - 3/21 14.3 7/69 10.1 29/276 10.5 39/370 10.5
MNG - - 2/21 9.5 3/69 4.3 20/276 7.2 25/370 6.8
Graves’ - - - - - - 2/276 0.7 2/370 0.5
Chronic 
thyroiditis - - 3/21 14.3 3/69 4.3 62/276 22.4 68/370 18.4
Total 0/4 - 8/21 38.1 21/69 30.4 129/276 46.6 158/370 42.7
Modern diagnostic methods allow detection of tumors even of minimal size. Our analysis 
of the presented material shows that thyroid nodule, multiple nodules, and Graves’ disease 
were the reason for surgical intervention in 75.2% of cases of microcarcinoma sized up to 
5 mm, and only in 24.3% cases sized from 6 to 10 mm. In the rest of cases, the papillary 
microcarcinoma was the main thyroid disease, and the main reason for surgery (Table 4.13). 
Concomitant chronic thyroiditis (presented in Table 4.13) was not the reason for surgery. 
Undoubtedly, tumors sized up to 1-2 mm could be detected incidentally only on microscopic 
examination of histological specimens from operated patients. If surgery was performed 
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for benign thyroid disease, e.g. multinodular goiter or Graves’ disease (Fig. 4.14 A-B), 
such microcarcinomas are considered to be “occult”. The presence of microcarcinomas 
sized 2 mm and larger may be suspected at a thorough examination of surgical material 
and during sample selection for subsequent microscopic analysis as demonstrated in the 
case of follicular adenoma (Fig. 4.14 C). 
 
Figure 4.14. Occult papillary microcarcinomas. (A, B) Nonencapsulated micro-PTCs sized 2 mm 
and 0.3 mm with the follicular growth pattern revealed in patients with Graves’ disease. Haematoxylin 
and eosin, original magnification x20, x100. (C) Nonencapsulated micro-PTCs sized 3 mm with the 
papillary-follicular growth pattern revealed in patients with follicular adenoma (FA). Haematoxylin 
and eosin, original magnification x20.
As a whole, our analysis of 2,478 cases of PTC showed the presence of concomitant 
thyroid disease in children in 11.0%, in adolescents in 16.9%, and in adults in 33.1% cases 
(Table 4.14). There was a significant ascending age-related linear trend (р=0.0001). The 
frequency of concomitant thyroid disease was also increasing in time from the first (1990-
1994) to the last (2005-2010) period of observation (р=0.0001 for trend). 
Besides the concomitant benign thyroid disease, additional coexisting thyroid cancers 
of smaller size than the PTC were noted in several cases; for this reason such tumors were 
referred to as “concomitant”. In 2 cases these were FTCs and in 2 cases MTCs (Table 4.14). One 
MTC in a boy who underwent hemithyroidectomy at the age of 7 years for a PTC with the solid 
structure, was diagnosed at repeated surgery (completion thyroidectomy, neck dissection at 
level VI) two years later [11,42]. The second MTC, sized 7 mm,  was identified in the left lobe of 
a female patient aged 25 years with a PTC sized 11 mm in the right lobe (Fig. 15 A-C).
Follicular adenomas were concomitant to PTC only in adults, beginning from the period 
2000-2004 (2.8%), and their frequency somewhat increased, though insignificantly, in the 
last period of observation (4.4%). 
Solitary and multiple (MNG) hyperplastic nodules were identified in all groups; their 
frequency significantly increased in a pairwise comparison: from 1.2% in children to 10.2% 
in adults (р=0.0001), and from 0.6% in 1990-1994 to 12.7% in 2005-2010 (р=0.0001); the 
ascending linear age and time trends were also significant (р=0.0001). 
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Figure 4.15. Two types of thyroid cancer coexisting in the same patient. (A) Nonencapsulated 
PTC with the papillary-solid growth pattern. Pronounced oxyphilic-cell metaplasia, Warthin-like loci. 
Haematoxylin and eosin, original magnification x20. (B) Nonencapsulated micro-medullary thyroid 
carcinoma with the solid growth pattern. Haematoxylin and eosin, original magnification x20. (C) 
Immunostaining of same area for calcitonin, original magnification x20.
PTCs in patients with Graves’ disease were detected in a small number of cases (1.6%), 
only in adults and only beginning from 2000, i.e. from the age of 32 years old. These were 
mainly “occult” cancers or those detected at visual examination of surgical material. PTCs 
sized more than 10 mm in patients with Graves’ disease were identified only in two cases. 
The frequency of concomitant marked chronic thyroiditis of grade 3+/4+ (focal 
thyroiditis of grade 1+/2+ was not taken into account) practically did not differ between 
children and adolescents (9.6% and 10.7%, respectively) but was significantly increased in 
adults in a pairwise comparison with both children (р=0.0011) and adolescents (р=0.0105). 
A significant increasе over time was observed between the first and last periods of 
observation (р=0.0007); the corresponding linear trend was also significant (р=0.0001). 
Thus, most morphological characteristics of PTC in children, adolescents and adults who 
were aged up to 18 years during Chernobyl accident, have two main patterns: age-related 
and time-related, which displayed significantly descending or ascending linear trends. 
Considering other types of thyroid cancer, it should be noted that follicular thyroid 
carcinoma (FTC) was detected in Ukraine in a small percentage of cases: 2.8% in children, 
7.3% in adolescents, and 5.2% in adults (Table 4.2), similarly to other countries affected by 
the Chernobyl catastrophe [7,10,14]. 
The tumors under study represented encapsulated solitary nodules exceeding 2 cm in 
more than 70% of cases (in all age groups). Tumors sized less than 1 cm were detected 
in 1 out of 18 cases in adolescents (5.6%) and in 7 out of 111 cases in adults (6.3%). Most 
FTCs had microfollicular-solid structure. The oxyphilic-cell variant of FTC was not found 
in children, but was identified in 2 cases in adolescents (11.1%) and in 11 cases (9.9%) in 
adults. The diagnosis of “follicular thyroid carcinoma” was based on generally accepted 
criteria: marked ”hook-like” or “mushroom-like” expansion through the tumor capsule and/
or in blood vessels of the tumor capsule (Fig. 4.16). 
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Table 4.14 
Сoncomitant thyroid diseases in patients with PTC born before Chernobyl
Pathology
Children aged up to 14 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
FTC - - - - - - - - - -
MTC 1/127* 0.8 - - - - - - 1/272 0.4
FA - - - - - - - - - -
Nodule - - 1/135 7.4 - - - - 1/272 0.4
MNG 1/127 0.8 1/135 7.4 - - - - 2/272 0.8
Graves’ - - - - - - - - - -
Chronic 
thyroiditis 8/127 6.3 16/135 11.9 2/10 20.0 - - 26/272  9.6
Total 10/127 7.9 18/135 13.3 2/10 20.0 - - 30/272 11.0
* - MTC, 12 mm, n/encaps, sol,T3N0M0 
Adolescents aged from 15 to 18 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
FTC - - - - 1/117* 0.9 - - 1/225 0.4
MTC - - - - - - - - - -
FA - - 2/81 2.5 4/117 3.4 - - 6/225 2.7
Nodule - - 2/81 2.5 3/117 2.6 - - 5/225 2.2
MNG - - 1/81 1.8 1/117 0.9 - - 2/225 0.9
Graves’ - - - - - - - - - -
Chronic 
thyroiditis 1/27 3.7 9/81 11.1 14/117 12.0 - - 24/225 10.7
Total 1/27 3.7 14/81 17.3 23/117 19.7 - - 38/225 16.9
* - FTC, 12 mm, microfol, T1bN0M0
Adults aged from 19 to 42 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
FTC - - - - - - 1/1214* 0.1 1/1981 0.05
MTC - - - - - - 1/1214** 0.1 1/1981 0.05
FA - - - - 17/605 2.8 53/1214 4.4 70/1981 3.5
Nodule - - 3/149 2.0 30/605 5.0 89/1214 7.3 122/1981 6.2
MNG - - 2/149 1.3 12/605 2.0 66/1214 5.4 80/1981 4.0
Graves’ - - - - 6/605 1.0 26/1214 2.1 32/1981 1.6
Chronic 
thyroiditis 1/13 7.7 21/149 14.1 104/605 17.2 224/1214 18.5 350/1981 17.7
Total 1/13 7.7 26/149 17.4 169/605 27.9 460/1214 37.9 656/1981 33.1
* - FTC, 10 mm, T1aN0M0; ** - MTC, 7 mm, encaps, sol, T1aN0M0
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Continuation of Table 4.14
All age groups
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
FTC - - - - 1/732 0.1 1/1214 01 2/2478 0.1
MTC 1/167 0.6 - - - - 1/1214 0.1 2/2478 0.1
FA - - 2/365 0.5 21/732 2.9 53/1214 4.4 76/2478 3.0
Nodule - - 6/365 1.6 33/732 4.5 89/1214 7.3 128/2478 5.2
MNG 1/167 0.6 4/365 1.1 13/732 1.8 66/1214 5.4 84/2478 3.4
Graves’ - - - - 6/732 0.8 26/1214 2.1 32/2478 1.3
Chronic 
thyroiditis 10/167 6.0 46/365 12.6 120/732 16.4 224/1214 18.5 400/2478 16.1
Total 12/167 7.2 58/365 15.9 194/732 26.5 460/1214 37.9 724/2478 29.2
Invasion of two and more capsular vessels was found in 108 out of 137 cases (78.8%); 
therefore, 21.2% of FTCs in children and adolescents born before Chernobyl were minimally 
invasive. An aggressive widely invasive FTC with extension to extrathyroidal connective 
tissue and the trachea, with regional metastases to lymph nodes and distant metastases to 
the lung (pT4aN1aM1) was observed only in one case in an adolescent female patient aged 
15 years whom we described earlier [42].
Figure 4.16. Follicular thyroid carcinomas. (A) Mushroom-like expansion through the capsule. 
Haematoxylin and eosin, original magnification x10. (B) Capsular invasion in a hook-like fashion. 
Haematoxylin and eosin, original magnification x50. (C, D) Vascular invasion. Aggregates of 
tumor cells are seen within the vessel lumen attached to the wall and covered by endothelium. 
Haematoxylin and eosin, original magnification x100, x50.
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Among thyroid diseases concomitant to FTC, PTC (represented mostly by 
microcarcinomas sized up to 10 mm) was detected in 5 adults (Table 4.15). In 1 case, an 
encapsulated PTC sized 21 mm was smaller than the coexisting FTC nodule (35 mm), and 
therefore it was referred to the category of “concomitant disease”. Solitary and multiple 
hyperplastic nodules were identified in 5.1%, chronic thyroiditis in the extratumoral tissue 
in 10.2% of cases. 
There are different opinions regarding the impact of radiation exposure on the 
development of FTC. Some authors suggest the existence of such [3,26,55] while other [56] 
have not revealed significant link between FTC and previous exposure. 
Our analysis of the frequency of FTC in Ukraine after Chernobyl in the group at high risk for 
radiation-induced thyroid cancer showed no significant differences between different age 
groups. However, a comparison of the frequency of FTC for different time periods after the 
accident revealed a significantly increasing linear trend (р=0.0334). Undoubtedly, 137 FTCs 
comprise too small number as compared to 2,478 PTCs, and further special investigations are 
needed to draw valid conclusions regarding association with thyroid dose.
Medullary thyroid carcinoma (MTC) in the cohort under study was diagnosed even less 
frequently: 2.4% in children, 0.4% in adolescents, and 1.5% in adults (Table 4.2). Tumor size 
varied from 4 to 75 mm; in 84.6% cases (33 out of 39) tumors were nonencapsulated, 87.2% 
carcinomas (34 out of 39) had the solid structure (Fig. 4.17), and only 12.8% displayed 
“spindle cell-solid” growth pattern. In all cases there was a positive immunohistochemical 
reaction with anti-calcitonin antibodies which confirmed the diagnosis of  MTC. Seven 
out of 8 MTCs in children and adolescents (87.5%) were characterized by extrathyroidal 
extension, metastases to lymph nodes (T3N1bМ0); 2 of these patients had distant 
metastases to the liver and brain (T3N1bM1). In adults, tumor aggressiveness was less 
pronounced: extrathyroidal extension and regional metastases were found in 12 out of 31 
(38.7%) cases, distant metastases to the liver were detected in 1 female patient (3.2%). In 
the latter patient with MEN 2A syndrome (she had been operated for pheochromocytoma 
before), a papillary microcarcinoma sized 0.2 cm was identified (Fig. 4.18). 
Here we do not analyze MTC in greater detail since many studies of post-Chernobyl 
thyroid cancer have not revealed any effect of radiation on the risk for development of 
tumors of this type [7,10,11,14]. 
Poorly differentiated thyroid carcinoma (PDTC) was diagnosed in 4 cases, all in adult 
female patients, accounting for 0.2% of all cancers under study (Table 4.2). Two of them 
were encapsulated, sized 26 and 35 mm, with trabecular-solid structure and invasion into 
tumor capsule and capsular vessels (T2N0M0). Both carcinomas developed in the presence 
of PTC as certain tumor areas displayed characteristic nuclear features. Two PDTCs were 
nonencapsulated, sized 50 and 52 mm, were of the insular and solid structure (T3N1bM0). In 
case of PDTC with the solid structure, the tumor was widely invasive (Fig. 4.19) with marked 
intrathyroidal and extrathyroidal extension, and necrotic areas. Tumor cells had signs of 
oxyphilic-cell metaplasia, were sometimes multinuclear, with marked nucleoli (Fig. 4.19 
B). In some tumor areas, a focal positive reaction with anti-thyroglobulin antibodies was 
revealed (Fig. 4.19 C); the reaction with anti-TTF-1 antibodies was diffuse and strong (Fig. 
4.19 D). A high proliferative activity of the tumor was confirmed by the reaction with anti-
Ki67 antibodies. In many areas there were more than 50.0% of positively stained nuclei (Fig. 
4.19 E). In such areas up to 20.0% of nuclei were also positive for TP53 (Fig. 4.19 F). 
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Figure 4.17. Medullary thyroid carcinoma. (A) Tumor with the solid growth pattern, marked 
stromal fibrosis, extrathyroidal extension and central necrosis. Haematoxylin and eosin, original 
magnification x10-panoramic. (B) Immunostaining for calcitonin of the same area, original 
magnification x20. (C) Tumor with the solid growth pattern and vascular invasion. Haematoxylin 
and eosin, original magnification x10. (D) Immunostaining for calcitonin of the same area. Marked 
C-cell hyperplasia in peritumoral areas, original magnification x10.
Table 4.15 
Concomitant thyroid diseases in patients with FTC born before Chernobyl
Pathology
Children aged up to 14 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
PTC -  -  -  -  -  -  -  -  -  -
MTC  -  -  -  -  -  -  -  -  -  -
FA  -  -  -  -  -  -  -  -  -  -
Nodule  -  -  -  -  -  -  -  -  -  -
MNG  -  -  -  -  -  -  -  -  -  -
Graves’  -  -  -  -  -  -  -  -  -  -
Total 0/2 - 0/6 - - - - - 0/8 -
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Continuation of Table 4.15
Adolescents aged from 15 to 18 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
PTC - - - - - - - - - -
MTC - - - - - - - - - -
FA - - - - 2 20.0 - - 2 11.1
Nodule - - - - 1 10.0 - - 1 5.6
MNG - - 1 14.3 - - - - 1 5.6
Graves’ - - - - - - - - - -
Chronic 
thyroiditis 1 - - - 1 10.0 - - 2 11.1
Total 1/1 - 1/7 14.3 4/10 40.0 - - 6/18 33.3
Adults aged from 19 to 40 years at surgery
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
PTC - - - - 2* 4.4 3* 4.9 5* 4.5
MTC - - - - - - - - - -
FA - - - - 1 2.2 - - 1 0.9
Nodule - - - - 1 2.2 5 8.2 6 5.4
MNG - - - - 2 4.4 4 6.6 6 5.4
Graves’ - - - - - - 1 1.6 1 0.9
Chronic 
thyroiditis - - - - 4 8.9 8 13.1 12 10.8
Total 0/1 - 0/4 - 10/45 22.2 21/61 34.4 31/111 27.9
* - PTCs: 21 mm, encaps, FV, T2N0M0; 8 mm, partly encaps, FV, T1aN0M0; 7, 6, mm, n/encaps, FV, 
T1aN0M0;  5 mm, n/encaps, PFV, T1aN0M0
All age groups
1990-1994 1995-1999 2000-2004 2005-2010 1990-2010
number % number % number % number % number %
PTC - - - - 2 3.6 3 4.9 5 3.6
MTC - - - - - - - - - -
FA - - - - 3 5.5 - - 3 2.2
Nodule - - - - 2 3.6 5 8.2 7 5.1
MNG - - - - 2 3.6 4 6.6 7 5.1
Graves’ - - - - - - 1 1.6 1 0.7
Chronic 
thyroiditis 1 25.0 1 5.9 5 9.1 8 13.1 14 10.2
Total 1/4 25.0 1/17 5.9 14/55 25.5 21/61 34.4 37/137 27.0
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Figure 4.18. Coexistence of two different types of thyroid carcinomas in one patient. (A) 
Encapsulated papillary microcarcinoma sized 2 mm with the classic growth pattern and cystic 
changes seen in vicinity to the nonencapsulated medullary thyroid carcinoma with the solid growth 
pattern. Haematoxylin and eosin, original magnification x100. (B) Immunostaining for calcitonin of 
the same area, original magnification x100. (C) Immunostaining for thyroglobulin of the same area, 
original magnification x100. 
In the most aggressive among all 4 PDTCs case, microfoci of PTC were also identified 
(Fig. 4.20). They were characterized by a strong reaction with antibodies to thyroglobulin 
(Fig. 4.20 D) and TTF-1 (Fig. 4.20 E), but unlike PDTC areas there were only isolated Ki67 
positive nuclei (Fig. 4.20 F). TP53 expression was not detected in the PTC areas. 
Tumor metastases completely replaced lymphatic nodes, and their structure and 
immunohistochemical characteristics did not differ from those of the main tumor (Fig. 4.21). 
The only difference was the lower frequency of nuclei positive for TP53: 5-10% (Fig. 4.21 F). 
Modern handbooks of thyroid pathology do not consider the role of radiation in the 
development of PDTC [3,4]. However, at least some tumors may develop from preexisting 
well-differentiated PTC or FTC. It could not be ruled out that radiation may promote 
dedifferentiation of PTC cells. In our series, patients’ age was 21 and 24 (encapsulated 
tumors) and 35 and 38 years old (nonencapsulated tumors), while typical mean age of 
patients with PDTC specified in handbooks is 55-60 years old. This issue, from our point 
of view, deserves particular attention in future, because 3 out of 4 cases of PDTC were 
detected in the last period of follow-up, namely, in 2008-2010.
Summarizing our data on pathology of thyroid cancer in Ukraine in the cohort aged 
from 0 to 18 years at the time of the Chernobyl accident, it should be noted that for the 
whole study period (1990-2010) the relative frequency of PTC exceeded 90.0% despite 
patients’ age at surgery increased over this period from 4 (the youngest children operated 
in 1990) to 42 years old (the oldest adults operated in 2010). Thus, PTC is undoubtedly the 
type of radiogenic «Chernobyl» cancer; this may be considered a proven fact. 
At the same time, a unique “structural portrait” of radiogenic Chernobyl PTC could 
not been established either by our group in Ukraine, or other authors [14,23,53,57]. Most 
likely, the development of PTC in patients of the group at risk (0 to 18 years at Chernobyl) 
followed the common mechanisms of thyroid carcinogenesis (yet displaying a higher or 
lower frequency of certain genetic abnormalities which correlate with structural changes 
in the tumor) that presumably underlie sporadic thyroid carcinogenesis. 
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Figure 4.19. Poorly differentiated thyroid carcinoma. (A) Widely invasive nonencapsulated 
tumor with the solid growth pattern. Marked fibrosis, necrotic foci, extrathyroidal extension. 
Haematoxylin and eosin, original magnification x10-panoramic. (B) High-power image of the same 
tumor. Numerous nuclei with prominent nucleoli. Haematoxylin and eosin, original magnification 
x100. (C) Focal immunostaining for thyroglobulin, original magnification x100. (D) Diffuse strong 
nuclear reactivity for TTF-1, original magnification x100. (E) Diffuse strong nuclear reactivity for Ki67. 
Original magnification x100. (F) Moderate nuclear reactivity for TP53, original magnification x100. 
Morphological characteristics of PTC are significantly changing with patients’ age 
at surgery and over time after Chernobyl, i.e. with latency.  Our analysis provides the 
evidence for two major patterns (age-related and time-related) seen for most pathological 
characteristics under study: “ascending” in some cases or “descending” in other linear trends. 
Significantly descending age and time trends are found for the frequency of architecturally 
less differentiated solid and solid-follicular subtypes of РТС, and invasive characteristics: 
intrathyroidal and extrathyroidal extension, vascular invasion, regional metastases to 
lymph nodes and distant metastases to the lung, which are important and favorable for 
the postoperative prognosis and patients’ quality of life.  
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Figure 4.20. Microfoci of papillary thyroid carcinoma in poorly differentiated thyroid carcinoma. 
(A) Fibrotic area with the papillary-follicular growth pattern. Haematoxylin and eosin, original 
magnification x50-panoramic. (B) Microfoci with the follicular growth pattern. Haematoxylin and 
eosin, original magnification x100. (C) Microfoci with the follicular growth pattern and numerous 
psammoma bodies in lymphatic vessel. Haematoxylin and eosin, original magnification x50. (D) 
Strong thyroglobulin immunostaining of PTC foci, original magnification x100. (E) Diffuse strong 
nuclear reactivity for TTF-1 in both PTC and PDTC areas, original magnification x50. (F) Isolated Ki-67 
positive nuclei in PTC foci. Original magnification x50. 
Ascending linear trends are established for the frequency of structurally more differentiated 
papillary and papillary-follicular subtypes of РТС, for the prevalence of tumors sized up to 10 
mm, and encapsulated tumors. These, again, may be considered as favorable, since “small” and 
encapsulated РТСs are characterized by significantly weaker invasive features compared with 
tumors of larger size and nonencapsulated ones. Thus, with increasing time after Chernobyl, 
PTC, based on its morphological characteristics, clearly becomes less aggressive. It would be 
difficult, however, to unambiguously determine if this is due only to the increasing patients’ 
age or also to the increasing with age frequency of sporadic PTC.  
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Figure 4.21. Lymph node metastasis of poorly differentiated thyroid carcinoma. (A) Metastasis 
of PDTC with the solid growth pattern completely replacing lymph node. Haematoxylin and eosin, 
original magnification x10-panoramic. (B) High-power image of the same section. Numerous nuclei 
with prominent nucleoli similar to those observed in the primary tumor. Haematoxylin and eosin, 
original magnification x100. (C) Focal immunostaining for thyroglobulin, original magnification 
x100. (D) Diffuse strong nuclear reactivity for TTF-1, original magnification x100. (E) Diffuse strong 
nuclear reactivity for Ki67. Original magnification x100. (F) Focal nuclear reactivity for TP53 showing 
labeling of 5% of the nuclei, original magnification x100. 
As an attempt to at least partly answer this question, a comparative analysis of 
morphological characteristics of PTCs detected in age-matched groups of patients born 
before Chernobyl (radiogenic РТСs) and after Chernobyl (sporadic, non-radiogenic РТСs) 
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